Showing results (851-860 of 14,979) with videos related to
Sort By:
Pageof 1,498
Kidney International|August 27, 2025
The Coming of Age for Polycystic Kidney DiseaseUyen A Tran, Oliver WesselyKidney International|July 19, 2016
The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysisJames B Wetmore, Haifeng Guo, Jiannong Liu, et al.Kidney International|September 1, 1989
Severe dialyzer dysfunction undetectable by standard reprocessing validation testsJ A Delmez, C A Weerts, P D Hasamear, et al.Kidney International|June 1, 1988
Glomerular prostaglandin production in diabetic rats with renovascular hypertensionR T Kopecky, E T SchroederKidney International|May 2, 2020
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumoniaFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.Kidney International|May 2, 2020
Lithocholic acid increases intestinal phosphate and calcium absorption in a vitamin D receptor dependent but transcellular pathway independent mannerNobuhiro Hashimoto, Isao Matsui, Satoshi Ishizuka, et al.Kidney International|May 4, 2020
Machine learning, the kidney, and genotype-phenotype analysisRachel S G Sealfon, Laura H Mariani, Matthias Kretzler, et al.Kidney International|June 17, 2020
Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipientsMario Fernández-Ruiz, Daniel Seron, Ángel Alonso, et al.Kidney International|October 26, 2019
Unraveling the osteocyte in CKD-MBD post-renal transplantationMarciana Laster, Renata C Pereira, Isidro B SaluskyKidney International|April 18, 2020
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatmentEric Rondeau, Marie Scully, Gema Ariceta, et al.Pageof 1,498